Interview: Oussama Badad: Chief Scientific Officer: Growmics
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
WM Technology to Delist from Nasdaq
IRVINE – WM Technology, Inc., the company behind the Weedmaps online Cannabis marketplace, announced that it will voluntarily pull its Class A common stock and warrants from the Nasdaq Global Select Market. The move comes ...
Bioxyne to Manufacture Medical Cannabis Products for Aurora Cannabis
SYDNEY – In a development that highlights the growing emphasis on dependable supply chains across the medical Cannabis sector, Bioxyne Limited has secured a manufacturing agreement with Aurora Cannabis Inc. to produce pharmaceutical-grade medicinal Cannabis ...
Distressed Assets Are Reshaping Cannabis M&A
LOS ANGELES- Distressed assets are now driving the next phase of Cannabis M&A. What appears on the surface to be a slowdown in deal activity is, in reality, a shift in how transactions are being ...
